Maxcyte (MXCT) Non Operating Interest Expenses (2020 - 2022)

Maxcyte (MXCT) has 3 years of Non Operating Interest Expenses data on file, last reported at $11000.0 in Q4 2022.

• On a quarterly basis, Non Operating Interest Expenses changed N/A year-over-year to $11000.0 in Q4 2022; TTM through Dec 2022 was $416000.0, a 60.17% decrease from a year earlier, with the FY2022 full-year figure at $127000.0, down 87.84% from the prior year.
• Non Operating Interest Expenses for Q4 2022 stood at $11000.0, down from $116000.0 in the prior quarter.
• Over the last five years, Non Operating Interest Expenses for MXCT reached as high as $742300.0 in Q1 2021 and fell as low as $11000.0 in Q4 2022.
• Historically, Non Operating Interest Expenses has averaged $235000.0 across 3 years, with a median of $213950.0 in 2020.
• On a YoY basis, Non Operating Interest Expenses climbed as much as 9.8% in 2021 and fell as far as 91.99% in 2021.
• Year by year, Non Operating Interest Expenses stood at $280600.0 in 2020, then rose by 2.99% to $289000.0 in 2021, then slumped by 96.19% to $11000.0 in 2022.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $11000.0 in Q4 2022, $116000.0 in Q3 2022, and $289000.0 in Q3 2021.